World's Best Scientists 2026 revealed!
María José Calasanz

María José Calasanz

D-Index & Metrics

Biology and Biochemistry

D-Index
71
Citations
19054
World Ranking
6606
National Ranking
107

Overview

María José Calasanz is affiliated with the University of Navarra in Spain and has made significant contributions to medical research, particularly in the field of hematology and molecular biology. Their work spans various areas within medicine, including cancer research and genetics.

Their recent publications highlight a focus on multiple myeloma and related hematological malignancies. Notable papers include:

  • Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma, 2020, Blood
  • Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma, 2022, Journal of Clinical Oncology
  • Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma, 2023, Nature Medicine
  • Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death, 2020, Cancer Discovery
  • Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma, 2020, Genome Research

Their research has been disseminated across several publication venues, frequently contributing to:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Cancers
  • HemaSphere
  • Leukemia

Coauthors with whom María José Calasanz has frequently collaborated include:

  • Joaquin Martínez-López
  • Jesús F. San Miguel
  • Bruno Paiva
  • María-Victoria Mateos
  • Pau Montesinos

The primary fields of study encompass medicine and biochemistry, genetics, and molecular biology, with subfields reflecting their detailed focus such as hematology, molecular biology, genetics, cancer research, and oncology.

  • Hematology
  • Molecular Biology
  • Genetics
  • Cancer Research
  • Oncology

The main topics that frame their research include:

  • Multiple Myeloma Research and Treatments
  • Acute Myeloid Leukemia Research
  • Protein Degradation and Inhibitors
  • Cancer Genomics and Diagnostics
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments

Best Publications

  • Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

    Mario F Fraga;Esteban Ballestar;Ana Villar-Garea;Manuel Boix-Chornet

  • Deregulated expression of cytokine receptor gene, CRLF2 , is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia

    Lisa J. Russell;Melania Capasso;Inga Vater;Takashi Akasaka

  • Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

    Miguel A. Sanz;Guillermo Martín;Marcos González;Angel León

  • Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Sílvia Beà;Rafael Valdés-Mas;Alba Navarro;Itziar Salaverria

  • Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

    Xabier Agirre;Amaia Vilas-Zornoza;Antonio Jiménez-Velasco;José Ignacio Martin-Subero

  • Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.

    J Boultwood;J Perry;A Pellagatti;M Fernandez-Mercado

  • Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

    José I Martín-Subero;Stefan Gesk;Lana Harder;Takashi Sonoki

  • Cytogenetic risk stratification in chronic myelomonocytic leukemia

    Esperanza Such;José Cervera;Dolors Costa;Francesc Solé

  • Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes

    Francesc Solé;Elisa Luño;Carmen Sanzo;Blanca Espinet

  • Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features

    Alba Navarro;Guillem Clot;Cristina Royo;Pedro Jares

  • Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.

    Xabier Agirre;Antonio Jiménez-Velasco;Edurne San José-Enériz;Leire Garate

  • Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.

    Jose Roman-Gomez;Antonio Jimenez-Velasco;Juan A. Castillejo;Xabier Agirre

  • Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

    Panagiotis Baliakas;Sabine Jeromin;Michalis Iskas;Anna Puiggros

  • Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia

    José Román-Gómez;Lucia Cordeu;Xabier Agirre;Antonio Jiménez-Velasco

  • Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

    Takashi Akasaka;Theodore Balasas;Lisa J Russell;Kei-ji Sugimoto

  • Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations

    María J. Calasanz;Juan C. Cigudosa;María D. Odero;Carmen Ferreira

  • Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

    Marta Salido;Cristina Baró;David Oscier;Kostas Stamatopoulos

  • Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy : long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

    Miguel A. Sanz;Pau Montesinos;Edo Vellenga;Consuelo Rayón

  • Epigenetic Regulation of MicroRNAs in Acute Lymphoblastic Leukemia

    Jose Roman-Gomez;Xabier Agirre;Antonio Jiménez-Velasco;Victor Arqueros

  • SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

    Ion Cristóbal;Francisco J. Blanco;Laura Garcia-Orti;Nerea Marcotegui

Frequent Co-Authors

Felipe Prosper
Felipe Prosper University of Navarra
Reiner Siebert
Reiner Siebert University of Ulm
Juan C. Cigudosa
Juan C. Cigudosa Instituto de Salud Carlos III
José I. Martín-Subero
José I. Martín-Subero University of Barcelona
Francesc Solé
Francesc Solé Autonomous University of Barcelona
Maria-Victoria Mateos
Maria-Victoria Mateos University of Salamanca
Miguel A. Sanz
Miguel A. Sanz University of Valencia
Marcos González
Marcos González University of Salamanca
Juan José Lahuerta
Juan José Lahuerta Complutense University of Madrid
Ramón García-Sanz
Ramón García-Sanz University of Salamanca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in biology or biochemistry, you’ll find a wide range of complementary online degrees and career pathways in the U.S. Many students pursue advanced degrees such as an cheapest online mba healthcare to boost their medical or scientific careers with leadership and management skills.

For those who enjoy working with data and healthcare information, medical billing and coding are in-demand career options. Gaining a certification such as certified professional coder can open doors to specialized roles in hospitals and clinics. Many wonder about the earning potential in this field; the certified medical coder salary reflects steady demand and competitive compensation, especially with experience and further credentials.

It’s important to weigh the medical billing and coding outlook before making a decision. While these paths offer flexible, remote-friendly work options, they also require attention to detail and ongoing certification. Whether you’re interested in advanced degrees or specialized certifications, the U.S. offers plenty of online choices for biology and biochemistry enthusiasts ready to diversify their career journey.

Best Scientists Citing María José Calasanz

Trending Scientists

Recently Published Articles